Hjem
Ruth Brenks bilde
  • E-postRuth.Brenk@uib.no
  • Telefon+47 55 58 60 70+47 960 40 226
  • Besøksadresse
    Jonas Lies vei 91
    Rom 
    5A125B
  • Postadresse
    Postboks 7804
    5020 Bergen

Our overall research goal is to improve methods used for structure-based drug design and to apply these methods to design inhibitors for enzymes with biological relevance. A key point in our research is the interplay of theoretical and experimental methods.

To read more about what we do, check out our homepage.

For a full list of publications, click here.

Vitenskapelig artikkel
  • 2019. Identification of a potential allosteric site of Golgi α-mannosidase II using computer-aided drug design. PLOS ONE. 1-19.
  • 2019. How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using N-Myristoyltransferases as a Model System. Journal of Medicinal Chemistry.
  • 2018. In silico identification and experimental validation of hits active against KPC-2 β-lactamase. PLOS ONE.
  • 2015. To hit or not to hit, that is the question -genome-wide structure-based druggability predictions for pseudomonas aeruginosa proteins. PLOS ONE.
Mastergradsoppgave
  • 2020. Structure-based design of pantothenate kinase inhibitors as lead structures for new antibiotics.
Vitenskapelig oversiktsartikkel/review
  • 2017. Ligand design for riboswitches, an emerging target class for novel antibiotics. 1649-1662.
Faglig kapittel
  • 2017. Structure-Based Discovery of Small Molecules Binding to RNA. . I:
    • 2017. RNA Therapeutics. Springer.

Se fullstendig oversikt over publikasjoner i CRIStin.

Forskergrupper